Current Ratio of OCULAR THERAPEUTIX, INC from 31 Mar 2015 to 31 Dec 2025
- Taxonomy & unit
- ratio: x
- Description
- The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
- Summary
-
OCULAR THERAPEUTIX, INC quarterly Current Ratio in x history and change rate from 31 Mar 2015 to 31 Dec 2025.
- OCULAR THERAPEUTIX, INC Current Ratio for the quarter ending 31 Dec 2025 was 11x, a 25% decline year-over-year.
Current Ratio, Quarterly (x)
Current Ratio, YoY Quarterly Change (%)
OCULAR THERAPEUTIX, INC Quarterly Current Ratio (x)
| Period | Value | YoY Chg | Change % | Date |
|---|---|---|---|---|
| Q4 2025 | 11x | -3.64x | -25% | 31 Dec 2025 |
| Q3 2025 | 9.62x | -4.12x | -30% | 30 Sep 2025 |
| Q2 2025 | 10.94x | -0.26x | -2.3% | 30 Jun 2025 |
| Q1 2025 | 12.36x | +4.51x | +57% | 31 Mar 2025 |
| Q4 2024 | 14.64x | +10.24x | +233% | 31 Dec 2024 |
| Q3 2024 | 13.73x | +10.01x | +269% | 30 Sep 2024 |
| Q2 2024 | 11.2x | +7.27x | +185% | 30 Jun 2024 |
| Q1 2024 | 7.85x | +3.19x | +69% | 31 Mar 2024 |
| Q4 2023 | 4.4x | -1.11x | -20% | 31 Dec 2023 |
| Q3 2023 | 3.72x | -2.63x | -41% | 30 Sep 2023 |
| Q2 2023 | 3.94x | -3.25x | -45% | 30 Jun 2023 |
| Q1 2023 | 4.66x | -3.45x | -43% | 31 Mar 2023 |
| Q4 2022 | 5.51x | -2.85x | -34% | 31 Dec 2022 |
| Q3 2022 | 6.36x | -2.52x | -28% | 30 Sep 2022 |
| Q2 2022 | 7.19x | -0.65x | -8.3% | 30 Jun 2022 |
| Q1 2022 | 8.11x | +0.99x | +14% | 31 Mar 2022 |
| Q4 2021 | 8.36x | +2x | +31% | 31 Dec 2021 |
| Q3 2021 | 8.88x | +4.07x | +85% | 30 Sep 2021 |
| Q2 2021 | 7.84x | +2.1x | +37% | 30 Jun 2021 |
| Q1 2021 | 7.12x | +1.46x | +26% | 31 Mar 2021 |
| Q4 2020 | 6.36x | -0.21x | -3.2% | 31 Dec 2020 |
| Q3 2020 | 4.8x | -2.15x | -31% | 30 Sep 2020 |
| Q2 2020 | 5.74x | -0.53x | -8.5% | 30 Jun 2020 |
| Q1 2020 | 5.66x | -0.2x | -3.4% | 31 Mar 2020 |
| Q4 2019 | 6.57x | +1.58x | +32% | 31 Dec 2019 |
| Q3 2019 | 6.95x | +2.62x | +61% | 30 Sep 2019 |
| Q2 2019 | 6.27x | +1.85x | +42% | 30 Jun 2019 |
| Q1 2019 | 5.85x | +1.34x | +30% | 31 Mar 2019 |
| Q4 2018 | 4.99x | -0.37x | -7% | 31 Dec 2018 |
| Q3 2018 | 4.33x | -2.35x | -35% | 30 Sep 2018 |
| Q2 2018 | 4.43x | -3.36x | -43% | 30 Jun 2018 |
| Q1 2018 | 4.51x | -5.45x | -55% | 31 Mar 2018 |
| Q4 2017 | 5.36x | -5.99x | -53% | 31 Dec 2017 |
| Q3 2017 | 6.68x | -7.37x | -52% | 30 Sep 2017 |
| Q2 2017 | 7.78x | -6.19x | -44% | 30 Jun 2017 |
| Q1 2017 | 9.96x | -3.93x | -28% | 31 Mar 2017 |
| Q4 2016 | 11.35x | -1.2x | -9.6% | 31 Dec 2016 |
| Q3 2016 | 14.05x | +2.59x | +23% | 30 Sep 2016 |
| Q2 2016 | 13.97x | +0.37x | +2.7% | 30 Jun 2016 |
| Q1 2016 | 13.89x | +1.94x | +16% | 31 Mar 2016 |
| Q4 2015 | 12.55x | 31 Dec 2015 | ||
| Q3 2015 | 11.46x | 30 Sep 2015 | ||
| Q2 2015 | 13.6x | 30 Jun 2015 | ||
| Q1 2015 | 11.95x | 31 Mar 2015 |
* An asterisk sign (*) next to the value indicates that the value is likely invalid.